Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
- PMID: 33153626
- PMCID: PMC7505567
- DOI: 10.1016/j.mayocp.2020.09.021
Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
Erratum in
-
Correction.Mayo Clin Proc. 2021 Apr;96(4):1095-1096. doi: 10.1016/j.mayocp.2021.01.019. Epub 2021 Feb 3. Mayo Clin Proc. 2021. PMID: 33814080 Free PMC article. No abstract available.
Figures
References
-
- Centers for Disease Control and Prevention Coronavirus disease 2019 (COVID-19): cases in the US. Published 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html
-
- USA Facts. Coronavirus Locations: COVID-19 Map by County and State. Published 2020. https://usafacts.org/visualizations/coronavirus-covid-19-spread-map/
-
- Beigel J.H., Tomashek K.M., Dodd L.E. Remdesivir for the treatment of COVID-19—preliminary report. N Engl J Med. 2020 - PubMed
-
- Luke T.C., Kilbane E.M., Jackson J.L., Hoffman S.L. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med. 2006;145(8):599–609. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
